PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. gbzhou@ioz.ac.cn.\', \'State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.\', \'State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. zchen@stn.sh.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11684-020-0773-x
?:hasPublicationType
?:journal
  • Frontiers of medicine
is ?:pmid of
?:pmid
?:pmid
  • 32318975
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.913
?:rankingScore_hIndex
  • 25
?:title
  • Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all